Listed

Nutex Health Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 16, 2021 and accepted by EDGAR at Aug 16, 2021, 13:13 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$5.3mus-gaap:Revenues
Revenue6 months2021-01-01 to 2021-06-30$7.3mus-gaap:Revenues
Cost of revenue3 months2021-04-01 to 2021-06-30$4.2mus-gaap:CostOfRevenue
Cost of revenue6 months2021-01-01 to 2021-06-30$5.8mus-gaap:CostOfRevenue
Gross profit3 months2021-04-01 to 2021-06-30$1.1mus-gaap:GrossProfit
Gross profit6 months2021-01-01 to 2021-06-30$1.5mus-gaap:GrossProfit
Research and development3 months2021-04-01 to 2021-06-30$59.6kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$136.3kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-04-01 to 2021-06-30−$936.9kus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$5.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-04-01 to 2021-06-30$2.0mus-gaap:InterestExpense
Interest expense6 months2021-01-01 to 2021-06-30$2.4mus-gaap:InterestExpense
Net income3 months2021-04-01 to 2021-06-30−$2.8mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30−$7.3mus-gaap:NetIncomeLoss
Operating cash flow6 months2021-01-01 to 2021-06-30−$2.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2021-06-30$4.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$5.6mus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$77.4mus-gaap:Assets
Current liabilitiesAt period end2021-06-30$7.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$10.1mus-gaap:Liabilities
Shareholders' equityAt period end2021-06-30$67.3mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001607062-21-000272. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.